Skip to Main Content

Paper Details

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.
JCI Insight
9
2021
5TGM1 MM cells, B cells, HDAC, HDAC11, HDACi, HDACs, IRF4, MM, MM cell lines, Mice, PC, Plasma cell, bortezomib, elevenostat, histone/protein deacetylase, histone/protein deacetylase 11, lysine103, mice, multiple myeloma, patient, patients, plasma cell, target promoter

Datasets

Release 1.2